Stock Graphs and Charts

This is a complete list of financial data submitted by La Jolla Pharmaceutical Co. to the Securities and Exchange Commission (SEC) in their recent 10K and 10Q filings. These terms are taken from the XBRL portion of the filings.

Click on a term to see historical data and generate a time series chart from the historical filings.

Term
Accounts Payable Current
Accrued Clinical
Accrued Liabilities Current
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Additional Paid In Capital Common Stock
Additional Working Capital
Adjustments To Additional Paid In Capital Dividends Preferred Stock
Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
Adjustments To Additional Paid In Capital Removal Of Redemption Rights
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Adjustments To Additional Paid In Capital Stock Split
Adjustments To Additional Paid In Capital Warrant Issued
Adjustments To Estimated Fair Value
Allocated Share Based Compensation Expense
Annual Base Salary For First Year Of Employment
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Assets
Assets Current
Awarded Options To Purchase Shares Of Common Stock
Business Acquisition Cost Of Acquired Entity Cash Paid
Cash And Cash Equivalents At Carrying Value
Cash And Cash Equivalents Period Increase Decrease
Cash Balance Required To Be Maintained Under Waiver Agreement
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
Cash Collateral For Borrowed Securities
Class Of Warrant Or Right Exercised During The Period
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
Class Of Warrant Or Right Outstanding
Common Shares Outstanding
Common Stock Available For Future Issuance
Common Stock Capital Shares Reserved For Future Issuance
Common Stock Issued During Period In Lieuof Cash For Services
Common Stock No Par Value
Common Stock Par Or Stated Value Per Share
Common Stock Shares Authorized
Common Stock Shares Issued
Common Stock Shares Outstanding
Common Stock Stated Price
Common Stock Value
Comprehensive Income Net Of Tax
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
Contractual Obligation
Contractual Obligation Due In Fourth Year
Contractual Obligation Due In Next Twelve Months
Contractual Obligation Due In Second Year
Contractual Obligation Due In Third Year
Conversion Of Preferred Stock Into Common Stock
Conversion Of Stock Amount Converted1
Conversion Of Stock Shares Converted1
Conversion Price Percentage Of New Preferred Stock
Cost Of Goods And Services Sold
Costs And Expenses
Cumulative Dividends Payable
Decrease In Par Value Of Capital Stock From Change In Par Value
Decrease Of Derivative Liability For Exercise Of Series D One Warrants To Series D One Preferred
Decrease Of Embedded Derivative Liabilities For Preferred Shares Converted Into Common Stock
Deferred Rent Credit
Deferred Rent Credit Current
Deferred Rent Credit Noncurrent
Deferred Tax Assets Capitalized Research And Development Costs
Deferred Tax Assets Gross
Deferred Tax Assets Liabilities Net
Deferred Tax Assets Net
Deferred Tax Assets Valuation Allowance
Defined Contribution Plan Cost Recognized
Depreciation
Derivative Gain Loss On Derivative Net
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
Derivative Liabilities Current
Dividends Preferred Stock Paidinkind
Earnings Per Share Basic
Earnings Per Share Basic And Diluted
Earnings Per Share Diluted
Embedded Derivative Fair Value Of Embedded Derivative Net
Employee Related Liabilities Current
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Exercise Price Of First Option Under Employment Agreement
Exercise Price Of Warrants
Exercise Price Series C Two Warrants Preferred
Exercise Price Series D One Warrants Preferred
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
Financing Transaction Costs
Forfeit Of Preferred Stock Dividends
Forfeiture Of Preferred Stock Dividends
Fully Vested Underlying Shares
Gain Loss On Disposition Of Assets1
General And Administrative Expense
Grants Vested During Period
Impairment Of Long Lived Assets To Be Disposed Of
Income Tax Examination Penalties And Interest Accrued
Income Tax Examination Penalties And Interest Expense
Income Tax Expense Benefit
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
Income Tax Reconciliation Change In Enacted Tax Rate
Income Tax Reconciliation Derivatives Fair Value
Income Tax Reconciliation Expired Tax Attributes
Income Tax Reconciliation Foreign Income Tax Rate Differential
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
Income Tax Reconciliation Other Reconciling Items
Income Tax Reconciliation Removal Of Net Operating Losses And Research And Development Credits
Income Tax Reconciliation State And Local Income Taxes
Income Tax Reconciliation Tax Credits Research
Increase Decrease In Accounts Payable
Increase Decrease In Accounts Payable And Accrued Liabilities
Increase Decrease In Accrued Liabilities
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
Increase Decrease In Deferred Rent
Increase Decrease In Derivative Liabilities
Increase Decrease In Employee Related Liabilities
Increase Decrease In Fair Value Of Unhedged Derivative Instruments
Increase Decrease In Inventories And Other Operating Assets
Increase Decrease In Other Operating Assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Increase Decrease In Prepaid Expenses Other
Increase Decrease In Restricted Cash
Increase Decrease In Restricted Cash And Investments For Operating Activities
Increase Decrease In Restricted Cash For Operating Activities
Increased In Annual Base Salary For First Year Of Employment
Incremental Common Shares Attributable To Conversion Of Preferred Stock
Initial Conversion Ratio Of New Preferred Stock To Common Stock
Interest Paid
Inventory Net
Issuance Of Stock And Warrants For Services Or Claims
Issuance Of Temporary Equity For Services
Issued Warrants To Purchase Shares
Lease And Rental Expense
Liabilities
Liabilities And Stockholders Equity
Liabilities Current
License Costs
Material Operating Leases
Net Cash Provided By Used In Financing Activities
Net Cash Provided By Used In Investing Activities
Net Cash Provided By Used In Operating Activities
Net Income Loss
Net Income Loss Available To Common Stockholders Basic
Net Income Loss Available To Common Stockholders Diluted
Net Increase In Liability Due To Accrual Of Dividends
Noncash Investingand Financing Activities Allowance For Tenant Improvements
Notes Payable Current
Number Of Operating Segments
Number Of Series C Two Received By Preferred Stockholders
Number Of Times Company And Purchasers Entered Into Amendment Agreements
Office Area Covered Under Operating Lease Agreement
Operating Costs And Expenses
Operating Income Loss
Operating Leases Future Minimum Payments Due
Operating Leases Future Minimum Payments Due Current
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Next Twelve Months
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalswithin Three Years
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalswithin Two Years
Operating Leases Future Minimum Payments Due Gross
Operating Leases Future Minimum Payments Due Gross Next Twelve Months
Operating Leases Future Minimum Payments Due In Five Years
Operating Leases Future Minimum Payments Due In Four Years
Operating Leases Future Minimum Payments Due In Three Years
Operating Leases Future Minimum Payments Due In Two Years
Operating Leases Future Minimum Payments Due Thereafter
Operating Leases Future Minimum Payments Gross Duein Three Years
Operating Leases Future Minimum Payments Gross Duein Two Years
Options Granted At Exercise Price
Other Accrued Liabilities Current
Other Assets
Other Nonoperating Income Expense
Payments To Acquire Intangible Assets
Payments To Acquire Property Plant And Equipment
Percentage Of Each Employee Base Salary Up To Which Employees May Purchase Common Stock
Percentage Of Employee Salaries Paid As Contribution
Percentage Of Fully Diluted Outstanding Common Stock
Percentage Of Investment Of Proceeds Contributed By Employee Maximum
Percentage Of Issued And Outstanding Common Stock
Percentage Of Underlying Shares On One Year Anniversary Of Employment
Preferred Stock Convertible Conversion To Common Stock Ratio
Preferred Stock Dividend Rate Percentage
Preferred Stock Liquidation Preference
Preferred Stock Par Or Stated Value Per Share
Preferred Stock Shares Authorized
Preferred Stock Value
Prepaid Clinical Expense
Prepaid Expense And Other Assets Current
Prepaid Expenseand Other Assets Excluding Clinical Expenses Current
Price Per Share Of Common Stock Discounted From Closing Market Prices
Proceeds From Issuance Of Common Stock
Proceeds From Issuance Of Convertible Preferred Stock
Proceeds From Issuance Of Preferred Stock And Preference Stock
Proceeds From Issuance Or Sale Of Equity
Proceeds From Preferred Stock Per Share
Proceeds From Repayments Of Restricted Cash Financing Activities
Proceeds From Stock Options Exercised
Proceeds From Warrant Exercises
Property Plant And Equipment Gross
Property Plant And Equipment Net
Purchase Commitment And Operating Lease
Purchase Of Common Stock Fully Diluted Converted Shares
Purchase Of Common Stock Shares
Reclassification Of Derivative Value Due To Removal
Reclassification Of Preferred Stock Not Currently Redeemable
Removal Of Redemption Rights Value
Research And Development Expense
Restricted Cash And Cash Equivalents
Restricted Cash And Cash Equivalents At Carrying Value
Restricted Cash And Cash Equivalents Noncurrent
Restricted Cash Current
Restricted Cash Noncurrent
Restricted Stock Expense
Retained Earnings Accumulated Deficit
Revenue From Contract With Customer Including Assessed Tax
Revenue From Related Parties
Revenues
Reversal Of Previously Accrued Dividends
Share Based Compensation
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Estimated Percentage Of Pre Vesting Forfeitures
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Share Based Compensation Arrangement By Share Based Payment Award Non Employee Stock Options Outstanding Number
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Sharebased Compensation Arrangement By Sharebased Payment Award Options Cancellations In Period
Sharebased Compensation Arrangement By Sharebased Payment Award Options Cancellations In Period Weighted Average Exercise Price
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Numberof Employees
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price As Percentage Of Fair Value Of Common Stock On Grant Date
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Sharebased Compensation Arrangementsby Sharebased Payment Award Otherthan Options Grantsin Period Weighted Average Exercise Price
Sharebased Compensation Arrangementsby Sharebased Payment Award Otherthan Options Vestedin Period Weighted Average Exercise Price
Shares Float
Shares Issued
Stockholders Equity
Stockholders Equity Note Reverse Stock Split Conversion Ratio
Stockholders Equity Note Stock Split Conversion Ratio1
Stock Issued1
Stock Issued During Period Employee Stock Purchase Plan Weighted Average Fair Value
Stock Issued During Period Shares Employee Stock Purchase Plans
Stock Issued During Period Shares Stock Options Exercised
Stock Issued During Period Value Conversion Of Convertible Securities
Stock Issued During Period Value Exchangeof Stock
Stock Issued During Period Value Issued For Services
Stock Issued During Period Value New Issues
Stock Issued During Period Value Restricted Stock Award Canceled
Stock Issued During Period Value Restricted Stock Award Gross
Stock Issued During Period Value Stock Dividend
Stock Issued During Period Value Stock Options Exercised
Stock Issued During Period Value Stock Warrants Exercised
Stock Option Plan Expense
Stock Option Vesting Proportion Per Month
Stock Redeemed Or Called During Period Value
Subsequent Event Amount
Suspension Of Preferred Stock Dividends
Temporary Equity Carrying Amount
Temporary Equity Carrying Amount Attributable To Parent
Temporary Equity Dividends Adjustment
Temporary Equity Issue Period Increase Or Decrease
Temporary Equity Liquidation Preference
Temporary Equity Par Or Stated Value Per Share
Temporary Equity Redemption Value
Temporary Equity Shares Authorized
Temporary Equity Shares Issued
Temporary Equity Shares Outstanding
Uncertain Income Tax Percentage Of Likelihood
Unrealized Gain Loss On Derivatives
Unrecognized Tax Benefits
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
Valuation Allowance Amount
Waiver Of Preferred Stock Holders Redemption Rights
Warrant Grantsto Third Parties Compensation Expense
Warrants And Rights Outstanding
Warrants Expired
Weighted Average Number Diluted Shares Outstanding Adjustment
Weighted Average Number Of Diluted Shares Outstanding
Weighted Average Number Of Share Outstanding Basic And Diluted
Weighted Average Number Of Shares Outstanding Basic
Weighted Average Number Of Shares Outstanding Basic And Diluted

Peers - Biological Products, Except Diagnostic Substances (Biotech) (2836)

Related News Stories

2 Stable and 2 Speculative Biotech Stocks to Buy | InvestorPlace

2018-06-15 investorplace
Biotech stocks represent a peculiar conundrum. On one hand, they are scientifically the most exciting investment sector. Successes here could spark revolutionary therapies that could end or at least alleviate human suffering. But the industry is heavily marked with failures and agonizing disappointments. (7-1)

Your Daily Pharma Scoop: Abeona Update, Alexion Data, Solid Biosciences Setback

2018-03-16 seekingalpha
Today we will discuss Abeona Therapeutics (ABEO) after the company announced that it has nabbed a Rare Pediatric Disease designation from the FDA for ABO-202 for the treatment of CLN1 disease, which is a rare inherited disorder of the nervous system. (159-4)

CUSIP: 503459604